• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.肌萎缩侧索硬化症(ALS)患者的调节性 T 淋巴细胞功能失调,与疾病进展速度和严重程度相关。
JCI Insight. 2017 Mar 9;2(5):e89530. doi: 10.1172/jci.insight.89530.
2
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis.肌萎缩侧索硬化症发病机制中的神经炎症机制。
Curr Opin Neurol. 2018 Oct;31(5):635-639. doi: 10.1097/WCO.0000000000000599.
3
Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.ALS 小鼠的调节性 T 淋巴细胞通过不同细胞因子介导的机制抑制小胶质细胞和效应 T 淋巴细胞。
Neurobiol Dis. 2012 Dec;48(3):418-28. doi: 10.1016/j.nbd.2012.07.008. Epub 2012 Jul 17.
4
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.调节性 T 淋巴细胞介导肌萎缩侧索硬化症的进展和存活。
EMBO Mol Med. 2013 Jan;5(1):64-79. doi: 10.1002/emmm.201201544. Epub 2012 Nov 9.
5
Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.调节性 T 细胞扩增与肌萎缩侧索硬化进展的关联:人类研究和转基因小鼠模型研究。
JAMA Neurol. 2018 Jun 1;75(6):681-689. doi: 10.1001/jamaneurol.2018.0035.
6
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.内源性调节性 T 淋巴细胞可改善小鼠肌萎缩侧索硬化症,并与肌萎缩侧索硬化症患者的疾病进展相关。
Brain. 2011 May;134(Pt 5):1293-314. doi: 10.1093/brain/awr074.
7
Autophagy dysregulation plays a crucial role in regulatory T-cell loss and neuroinflammation in amyotrophic lateral sclerosis (ALS).自噬失调在肌萎缩侧索硬化症(ALS)中调节性 T 细胞缺失和神经炎症中发挥着关键作用。
Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):336-344. doi: 10.1080/21678421.2023.2273365. Epub 2023 Nov 1.
8
Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation.人源 CD4+CD25+ T 细胞表达针对异常超氧化物歧化酶 1 的嵌合抗原受体可触发抗原特异性免疫调节。
Cytotherapy. 2024 Feb;26(2):126-135. doi: 10.1016/j.jcyt.2023.11.007. Epub 2023 Dec 3.
9
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.一种稳健的、符合药品生产质量管理规范的临床规模程序,用于从肌萎缩侧索硬化症患者中生成调节性T细胞以进行过继性细胞治疗。
Cytotherapy. 2016 Oct;18(10):1312-24. doi: 10.1016/j.jcyt.2016.06.012. Epub 2016 Aug 3.
10
Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.胸腺刺激CD4 + T细胞扩增对突变型SOD1小鼠疾病发生和进展的影响。
J Neuroinflammation. 2015 Feb 27;12:40. doi: 10.1186/s12974-015-0254-3.

引用本文的文献

1
Peripheral immune patterns enable robust cross-platform prediction of ALS onset and progression.外周免疫模式能够实现对肌萎缩侧索硬化症发病和进展的强大跨平台预测。
bioRxiv. 2025 Aug 27:2025.08.26.672381. doi: 10.1101/2025.08.26.672381.
2
The metabolic intersection between immunosenescence and neuroinflammation in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中免疫衰老与神经炎症之间的代谢交叉点。
J Inflamm (Lond). 2025 Aug 27;22(1):36. doi: 10.1186/s12950-025-00460-y.
3
Early immune system changes in amyotrophic lateral sclerosis correlate with later disease progression.肌萎缩侧索硬化症早期免疫系统变化与疾病后期进展相关。
Med. 2025 Aug 8;6(8):100673. doi: 10.1016/j.medj.2025.100673. Epub 2025 Apr 25.
4
The systemic inflammation markers as potential predictors of disease progression and survival time in amyotrophic lateral sclerosis.全身炎症标志物作为肌萎缩侧索硬化症疾病进展和生存时间的潜在预测指标。
Front Neurosci. 2025 Mar 5;19:1552949. doi: 10.3389/fnins.2025.1552949. eCollection 2025.
5
Tregs levels and phenotype modifications during Amyotrophic Lateral Sclerosis course.肌萎缩侧索硬化症病程中调节性T细胞水平及表型改变
Front Immunol. 2025 Jan 8;15:1508974. doi: 10.3389/fimmu.2024.1508974. eCollection 2024.
6
Cortical thickness correlated with peripheral inflammatory cytokines in amyotrophic lateral sclerosis.在肌萎缩侧索硬化症中,皮质厚度与外周炎性细胞因子相关。
Front Neurosci. 2025 Jan 7;18:1514554. doi: 10.3389/fnins.2024.1514554. eCollection 2024.
7
C9orf72 role in myeloid cells: new perspectives in the investigation of the neuro-immune crosstalk in amyotrophic lateral sclerosis and frontotemporal dementia.C9orf72在髓样细胞中的作用:肌萎缩侧索硬化症和额颞叶痴呆神经免疫相互作用研究的新视角
Ann Transl Med. 2024 Dec 24;12(6):120. doi: 10.21037/atm-24-86. Epub 2024 Oct 14.
8
Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis.脂质介导的肌萎缩侧索硬化症炎症消退与存活
Brain Commun. 2025 Jan 15;7(1):fcae402. doi: 10.1093/braincomms/fcae402. eCollection 2025.
9
Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis.针对常见疾病发病机制治疗肌萎缩侧索硬化症。
Nat Rev Neurol. 2025 Feb;21(2):86-102. doi: 10.1038/s41582-024-01049-4. Epub 2025 Jan 2.
10
Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study.辅助性T细胞17及效应性CD8 T细胞与肌萎缩侧索硬化症的疾病进展相关:一项病例对照研究。
J Neuroinflammation. 2024 Dec 27;21(1):331. doi: 10.1186/s12974-024-03327-w.

本文引用的文献

1
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy.一种稳健的、符合药品生产质量管理规范的临床规模程序,用于从肌萎缩侧索硬化症患者中生成调节性T细胞以进行过继性细胞治疗。
Cytotherapy. 2016 Oct;18(10):1312-24. doi: 10.1016/j.jcyt.2016.06.012. Epub 2016 Aug 3.
2
Type 1 diabetes immunotherapy using polyclonal regulatory T cells.使用多克隆调节性T细胞的1型糖尿病免疫疗法。
Sci Transl Med. 2015 Nov 25;7(315):315ra189. doi: 10.1126/scitranslmed.aad4134.
3
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.适应性免疫在神经退行性疾病中的双重破坏和保护作用。
Transl Neurodegener. 2014 Nov 13;3(1):25. doi: 10.1186/2047-9158-3-25. eCollection 2014.
4
The Treg-specific demethylated region stabilizes Foxp3 expression independently of NF-κB signaling.调节性T细胞特异性去甲基化区域独立于核因子κB信号传导稳定叉头框蛋白3表达。
PLoS One. 2014 Feb 5;9(2):e88318. doi: 10.1371/journal.pone.0088318. eCollection 2014.
5
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.免疫介导机制在肌萎缩侧索硬化症的发病机制中的作用。
J Neuroimmune Pharmacol. 2013 Sep;8(4):888-99. doi: 10.1007/s11481-013-9489-x. Epub 2013 Jul 25.
6
Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.调节性 T 淋巴细胞介导肌萎缩侧索硬化症的进展和存活。
EMBO Mol Med. 2013 Jan;5(1):64-79. doi: 10.1002/emmm.201201544. Epub 2012 Nov 9.
7
Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms.ALS 小鼠的调节性 T 淋巴细胞通过不同细胞因子介导的机制抑制小胶质细胞和效应 T 淋巴细胞。
Neurobiol Dis. 2012 Dec;48(3):418-28. doi: 10.1016/j.nbd.2012.07.008. Epub 2012 Jul 17.
8
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.内源性调节性 T 淋巴细胞可改善小鼠肌萎缩侧索硬化症,并与肌萎缩侧索硬化症患者的疾病进展相关。
Brain. 2011 May;134(Pt 5):1293-314. doi: 10.1093/brain/awr074.
9
FOXP3+ regulatory T cells in the human immune system.FOXP3+ 调节性 T 细胞在人类免疫系统中的作用。
Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18.
10
Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice.调节性 CD4+CD25+ T 细胞诱导小鼠巨噬细胞表型和功能的转换。
Immunol Cell Biol. 2011 Jan;89(1):130-42. doi: 10.1038/icb.2010.70. Epub 2010 Jun 1.

肌萎缩侧索硬化症(ALS)患者的调节性 T 淋巴细胞功能失调,与疾病进展速度和严重程度相关。

ALS patients' regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity.

机构信息

Peggy and Gary Edwards ALS Laboratory, Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, Texas, USA.

Department of Surgery, University of Florida, Gainesville, Florida, USA.

出版信息

JCI Insight. 2017 Mar 9;2(5):e89530. doi: 10.1172/jci.insight.89530.

DOI:10.1172/jci.insight.89530
PMID:28289705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5333967/
Abstract

Neuroinflammation is a pathological hallmark of ALS in both transgenic rodent models and patients, and is characterized by proinflammatory T lymphocytes and activated macrophages/microglia. In ALS mouse models, decreased regulatory T lymphocytes (Tregs) exacerbate the neuroinflammatory process, leading to accelerated motoneuron death and shortened survival; passive transfer of Tregs suppresses the neuroinflammation and prolongs survival. Treg numbers and FOXP3 expression are also decreased in rapidly progressing ALS patients. A key question is whether the marked neuroinflammation in ALS can be attributed to the impaired suppressive function of ALS Tregs in addition to their decreased numbers. To address this question, T lymphocyte proliferation assays were performed. Compared with control Tregs, ALS Tregs were less effective in suppressing responder T lymphocyte proliferation. Although both slowly and rapidly progressing ALS patients had dysfunctional Tregs, the greater the clinically assessed disease burden or the more rapidly progressing the patient, the greater the Treg dysfunction. Epigenetically, the percentage methylation of the Treg-specific demethylated region was greater in ALS Tregs. After in vitro expansion, ALS Tregs regained suppressive abilities to the levels of control Tregs, suggesting that autologous passive transfer of expanded Tregs might offer a novel cellular therapy to slow disease progression.

摘要

神经炎症是转(transgenic)基因(transgenic)啮齿动物模型和患者中 ALS 的病理标志之一,其特征为促炎 T 淋巴细胞和活化的巨噬细胞/小胶质细胞。在 ALS 小鼠模型中,调节性 T 淋巴细胞(Tregs)减少会加重神经炎症过程,导致运动神经元更快死亡和生存时间缩短;Tregs 的被动转移可抑制神经炎症并延长生存时间。在快速进展的 ALS 患者中,Treg 数量和 FOXP3 表达也减少。一个关键问题是,除了数量减少之外,ALS Tregs 抑制功能受损是否导致 ALS 中明显的神经炎症。为了解决这个问题,进行了 T 淋巴细胞增殖测定。与对照 Tregs 相比,ALS Tregs 抑制应答 T 淋巴细胞增殖的效果较差。虽然缓慢和快速进展的 ALS 患者均存在功能失调的 Tregs,但临床评估的疾病负担越大或患者进展越快,Treg 功能障碍越大。表观遗传上,ALS Tregs 中 Treg 特异性去甲基化区域的甲基化百分比更大。体外扩增后,ALS Tregs 恢复了对对照 Tregs 的抑制能力,表明扩增的 Tregs 的自体被动转移可能为减缓疾病进展提供一种新的细胞治疗方法。